Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PERSPECTIVE THERAPEUTICS INC.

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
Listen to this Section


$2.97
-0.0050 ( -0.17% ) 674.1K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open $2.97
Previous Close $2.97
Volume 674.1K
Market Cap $338.72M
Day Range $2.94 - $3.06
52 Week Range $1.96 - $6.16
Shares Outstanding 114.05M
Change % -0.17%
Net Change ▼ -0.0050
Insider Ownership 0.01%
Exchange NYSE AMERICAN
SectorHealthcare
IndustryMedical/Dental Instruments
IPO Year2003
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 53,486,811.00

Date Type Amount Purchased Purchaser
2025-11-14 Buy 9498.00 Williamson Robert F III
2025-11-14 Buy 9498.00 Williamson Robert F III
2025-11-14 Buy 9498.00 Williamson Robert F III
2024-12-06 Buy 25975.00 HENSON HEIDI
2024-12-04 Buy 8000.00 Spoor Johan M.
2024-11-27 Buy 400.00 Hunt Jonathan Robert
2024-11-27 Buy 3647.00 Williamson Robert F III
2024-11-26 Buy 14500.00 Spoor Johan M.
2024-07-19 Sale -34500.00 Austin Mark John
2024-06-24 Sale -23000.00 Williamson Robert F III

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 14, 2025
8-k 8K-related 81 Nov 10, 2025
10-q Quarterly Reports 69 Nov 10, 2025
8-k 8K-related 77 Nov 06, 2025
8-k 8K-related 10 Nov 03, 2025
8-k 8K-related 44 Oct 20, 2025
8-k 8K-related 75 Oct 01, 2025
4 Insider transactions 1 Sep 05, 2025
3 Insider transactions 2 Sep 05, 2025
3 Insider transactions 2 Sep 05, 2025

Latest News


× Before browsing our site, please accept our cookies policy